Magnesium Sulphate in Premature Rupture of Membranes

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To assess the outcome of using magnesium sulphate on fetus and women with preterm premature rupture of membranes

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assiut University
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• pregnant women with gastational age between 28 weeks and 36 weeks and 6 days who are diagnosed with preterm prelabour rupture of membranes

Exclusion Criteria:

• clinical suspicion of chorioamnionitis

• Patients refusal to participate in clinical research.

• significant vaginal bleeding

• previous tocolysis use after rupture of membranes

• nonreassuring fetal heart tracing

• fetal anomalies

• significant maternal medical complications, and maternal or fetal indication for delivery